Ledger.Open graph →
SEC Form D · Amendment · filed December 9, 2025

Araceli Biosciences Inc

Offering
$14.1M
Sold
$12.2M
Exemption
Rule 506(b)
Industry
Other Technology
Location
TIGARD, OR
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Shawn Macdonald · Tigard, ORExecKirk Malloy · Tigard, ORDirectorSean O'Neill · Tirgard, ORDirectorBruce Rhine · Tigard, ORDirectorMatt Beaudet · Tigard, ORExec · DirectorKevin Gabelein · Tigard, ORDirectorJ. William Freytag · Tigard, ORDirectorWilliam Cortelyou · Tigard, ORDirectorSamraat Raha · Tigard, ORDirectorKevin Gabelein · Tigard, ORDirectorKirk Malloy · Tigard, ORDirectorWilliam Cortelyou · Tigard, ORDirectorJ. William Freytag · Tigard, ORDirectorSean O'Neill · Tirgard, ORDirectorSamraat Raha · Tigard, ORDirectorShawn Macdonald · Tigard, ORExecBruce Rhine · Tigard, ORDirectorMatt Beaudet · Tigard, ORExec · DirectorNakul Mandan · San Francisco, CADirectorPaul Daversa · WESTPORT, CTDirectorEd Bachtold · BELLEVUE, WADirectorScott Rerucha · BELLEVUE, WADirectorJarrett Johnson · BELLEVUE, WADirectorBrent Eley · BELLEVUE, WAExecChris Steward · BELLEVUE, WAExec · DirectorChris Gurdjian · BELLEVUE, WADirectorShakti C'Ganti · Southlake, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗